Jericho Financial LLP Sells 5,786 Shares of Chemed Corporation $CHE

Key Points

• Jericho Financial LLP trimmed its position in Chemed by 82.1% in Q4, selling 5,786 shares and ending the period with 1,260 shares worth $539,000.
• CEO Kevin J. McNamara sold 2,000 shares on March 12 at an average price of $403.18, cutting his stake by 2.09% to 93,719 shares; insiders now own 3.29% of the company.
• Chemed missed quarterly EPS ($6.42 vs. $7.02 expected) with slightly lower revenue, issued FY2026 guidance of $23.25–$24.25 EPS, and has a Street consensus rating of Hold with a $498 price target.

Jericho Financial LLP trimmed its position in shares of Chemed Corporation (NYSE:CHE - Free Report) by 82.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,260 shares of the company's stock after selling 5,786 shares during the period. Jericho Financial LLP's holdings in Chemed were worth $539,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. raised its position in Chemed by 122.7% during the third quarter. JPMorgan Chase & Co. now owns 499,968 shares of the company's stock valued at $223,856,000 after purchasing an additional 275,423 shares in the last quarter. AQR Capital Management LLC grew its stake in shares of Chemed by 160.9% during the second quarter. AQR Capital Management LLC now owns 201,041 shares of the company's stock worth $97,893,000 after buying an additional 123,982 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its stake in shares of Chemed by 740.9% during the third quarter. Arrowstreet Capital Limited Partnership now owns 95,573 shares of the company's stock worth $42,792,000 after buying an additional 84,208 shares during the last quarter. Epoch Investment Partners Inc. grew its stake in shares of Chemed by 29.4% during the third quarter. Epoch Investment Partners Inc. now owns 307,275 shares of the company's stock worth $137,579,000 after buying an additional 69,878 shares during the last quarter. Finally, UBS Group AG grew its stake in shares of Chemed by 104.2% in the third quarter. UBS Group AG now owns 112,118 shares of the company's stock worth $50,200,000 after purchasing an additional 57,201 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors.

Insider Activity

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $403.18, for a total value of $806,360.00. Following the transaction, the chief executive officer owned 93,719 shares in the company, valued at approximately $37,785,626.42. The trade was a 2.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 3.29% of the company's stock.

Chemed Price Performance

Shares of NYSE:CHE opened at $388.50 on Wednesday. The firm has a fifty day moving average price of $418.80 and a two-hundred day moving average price of $431.73. Chemed Corporation has a one year low of $365.20 and a one year high of $604.91. The company has a market cap of $5.35 billion, a price-to-earnings ratio of 21.15, a PEG ratio of 1.51 and a beta of 0.49.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings results on Wednesday, February 25th. The company reported $6.42 EPS for the quarter, missing the consensus estimate of $7.02 by ($0.60). Chemed had a net margin of 10.48% and a return on equity of 25.66%. The firm had revenue of $639.34 million during the quarter, compared to the consensus estimate of $659.09 million. During the same period in the previous year, the business earned $6.83 earnings per share. The firm's revenue for the quarter was down .1% on a year-over-year basis. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. Equities research analysts expect that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Monday, February 23rd were given a $0.60 dividend. The ex-dividend date was Monday, February 23rd. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. Chemed's payout ratio is presently 13.06%.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. Weiss Ratings reissued a "hold (c-)" rating on shares of Chemed in a research note on Wednesday, January 21st. Jefferies Financial Group lowered shares of Chemed from a "buy" rating to a "hold" rating in a report on Thursday, January 22nd. Royal Bank Of Canada reaffirmed a "sector perform" rating and issued a $422.00 price target (down from $572.00) on shares of Chemed in a research report on Friday, February 27th. Oppenheimer dropped their price target on shares of Chemed from $580.00 to $500.00 and set an "outperform" rating on the stock in a research report on Friday, February 27th. Finally, Zacks Research lowered shares of Chemed from a "hold" rating to a "strong sell" rating in a research note on Wednesday, March 4th. Two research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $498.00.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.